Early-stage companies hurting for cash, while some older ones manage to conserve capital - bizjournals:

lebexab.wordpress.com
“We’re just very pleased with this and we expect that Yamatake will be a very positiv corporate partner in Manzer said. “It’s a bright spot for Tucson and all of The entire BioVigilant management team will remain in but will get additional humaj resources by conducting joiny projectswith Yamatake’s engineering and manufacturing Manzer said BioVigilant’s customer relationshi p with Yamatake was crucial for takinhg their partnership to the next level. “The sooner you establisb a major customer that paves the way for you and gives you Manzer said.
“I think at this point, we’re going to see very positivee reaction from the industry thatwe serve, because now they’re goiny to say we have the credibility of a $2.5 billionm company behind BioVigilant.” Jonah chairman and CEO of in Scottsdale, said he hasn’ty worried about gaining access to the capitalp markets for many years because his companyh is sitting on half a billion dollare in its treasury. Founded in Medicis had a record 2008. Even though it is more than twodecaded old, it still faces some challenges. Saleds have been down for the company’ Restylane product, a nonsurgical prescription dermal fillere for linesand wrinkles.
Shacknai acknowledged the Restylaner franchise has been soft because consumers are tightening theirr purse strings duringthe recession. “We have managexd expenses to compensate for the lost revenues inthat sector,” he He said the companies that survive are those whosd management and employees have the willpower and passionj to see things through. “It’as a time never to be proud (and) never be on a high horse,” Shacknaoi said.
“The CEO needs to be washinbg dishes with everyone else to realludemonstrate there’s a shareds commitment to the future, and everyone pitches